Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients
1 ビュー
• 07/14/23
0
0
埋め込む
administrator
加入者
Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.
もっと見せる
フェイスブックのコメント
SORT BY-
トップコメント
-
最新のコメント